Supporting people in hospitals across South Australia through vital health and medical research and improved patient care.
Meet our passionate and dedicated team.
Meet our Board and Governance team.
THRF adopts extremely high transparency standards when reporting our financials.
Supports research into the detection, management & treatment of breast cancer.
Funding research into prostate cancer prevention, detection & treatment.
Improving heart health through advances in knowledge & research to beat heart disease.
Our aim is to reduce & eliminate the high incidence of chronic kidney disease and diabetes.
Supports health and wellbeing research & programs for veterans, emergency service personnel and their families.
Driving collaboration, innovation & research to develop best-practice arts, design & health programs.
Supporting world-class stroke research to improve prevention, diagnosis & acute treatment to cure stroke.
Providing donor stool to treat patients with bowel conditions and foster research into faecal transplant as a treatment.
Do you want to join our team? Check out current career opportunities here.
View some of the commonly asked questions about our organisation.
We are so grateful to those who donate their time and skills to support life-changing medical research. Find out more…
Get in touch with us here.
The CCB is an alliance between SA Pathology and the University of South Australia and boasts over 200 cancer researchers; currently hosting 22 full-time research group leaders and their teams.
CCB laboratories carry out research on the major cancers such as leukaemia, bowel cancer, breast cancer, prostate cancer, lung cancer, ovarian cancer and skin cancers led by distinguished full-time group leaders. A particular focus is childhood cancers and cancers that occur in the same family. In addition to these laboratories, the CCB’s ACRF Cancer Genomics Facility provides access to state-of-the-art genomics to bring precision medicine to South Australian cancer patients.
The translation of new discoveries into clinical practice is strengthened by the location of the laboratories within a single centre, as well as its proximity to the Royal Adelaide Hospital along with its clinical resources, the University of South Australia and the University of Adelaide, with which it shares key research facilities.
The CCB has alliances with other prominent national and international Institutes and leading pharmaceutical companies which have allowed many of the discoveries made in this Institute, by South Australians, to be in advanced clinical trials worldwide. In this way the CCB is becoming a hub of internationally recognised cancer research excellence, achieving tangible outcomes for cancer patients.
The CCB is a member of the Association of Australian Medical Research Institutes (AAMRI).
support the centre for cancer biology
The Hospital Research Foundation is proud to be funding new research into leukaemia treatments which has made exciting breakthroughs for patients suffering from the debilitating blood cancer, myelofibrosis. read more
Scientists working tirelessly in the lab of the Centre for Cancer Biology have identified that high levels of a protein (called quaking) plays a key role in the bad prognosis of prostate cancer tumours that have become resistant to chemotherapy and other treatments. read more
Did you know, every day in Australia approximately 50 people are diagnosed with breast cancer? read more
Always fit and healthy, 56-year-old Deb Holsman never thought she would be diagnosed with breast cancer, let alone one of the most heartbreaking forms of the disease. read more
Adelaide researchers from the Centre for Cancer Biology (CCB) have discovered for the first time a protein previously linked to controlling blood pressure also prevents salt-induced kidney disease. read more
Cancer survivor and artist Doug is determined to raise funds for cancer research to help others who may not be as fortunate as him. read more
Thanks to our generous community, The Hospital Research Foundation (THRF) supports lifesaving research that will see new and improved treatments for common diseases reach our community sooner.
Just recently THRF directed $75,000 in funding to Dr Natasha Harvey and her world-class team at the Centre for Cancer Biology (CCB) to support their vital work into halting the spread of common cancers and the condition of lymphoedema. read more
Head of the Cell Signalling Laboratory at the Centre for Cancer Biology (CCB), Associate Professor Yeesim Khew-Goodall is leading a crucial research project focused on overcoming resistance to cancer therapy, particularly in triple negative breast cancer. read more
An exciting study is underway that could potentially lead to new treatments for metastatic prostate cancer (cancer that spreads around the body) at the Centre for Cancer Biology (CCB). read more